Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
Fish and Richardson
McKinsey
Covington
UBS
Queensland Health
Deloitte
Colorcon

Generated: August 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078193

« Back to Dashboard

NDA 078193 describes RALOXIFENE HYDROCHLORIDE, which is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Glenmark Pharms Ltd, Invagen Pharms, Sciegen Pharms Inc, Teva Pharms Usa, and Watson Labs Inc, and is included in seven NDAs. It is available from eighteen suppliers. Additional details are available on the RALOXIFENE HYDROCHLORIDE profile page.

The generic ingredient in RALOXIFENE HYDROCHLORIDE is raloxifene hydrochloride. There are sixteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the raloxifene hydrochloride profile page.
Summary for 078193
Tradename:RALOXIFENE HYDROCHLORIDE
Applicant:Teva Pharms Usa
Ingredient:raloxifene hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 078193
Suppliers and Packaging for NDA: 078193
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 078193 ANDA Teva Pharmaceuticals USA, Inc. 0093-7290 N 0093-7290-01
RALOXIFENE HYDROCHLORIDE raloxifene hydrochloride TABLET;ORAL 078193 ANDA Teva Pharmaceuticals USA, Inc. 0093-7290 N 0093-7290-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength60MG
Approval Date:Mar 4, 2014TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fuji
US Army
Cerilliant
Daiichi Sankyo
Cipla
QuintilesIMS
Argus Health
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.